Furthermore, VSC-CDs demonstrated the ability to modulate the TGF-β/Smad signaling pathway and regulate the protein expressions of α-SMA and COI1, thereby inhibiting the progression of liver fibrosis. The gene discussed is ACTA1; the disease is Hepatic fibrosis.